Company Description
China Dasheng Biotechnology Co (CDBT) is a company engaged in the development and commercialization of new geometric configuration low carbon emission engines and other clean technology solutions. Recently, CDBT has terminated a consulting agreement with Kenneth Maciora, Empire Relations Group Inc., and Empire Holdings LLC due to failure to deliver work product. With a focus on reducing greenhouse emissions and improving efficiency, CDBT aims to create technologies that make a positive impact on the environment. The company has acquired Cycclone Magnetic Engines, Inc., a pioneering company in the clean technology industry with interests in transport operations in Australia.
Stock Performance
Latest News
SEC Filings
No SEC filings available for Cycclone.